Loading
Life sciences · Journal article
Ural Medical Journal · November 2, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Introduction. Modern management of menopausal transition and early postmenopause views climacteric syndrome (CS) as a systemic, multiorgan pathology linked to increased cardiometabolic risk, requiring a multidisciplinary approach. The aim of this study is to determine the prevalence of metabolic syndrome (MS) and its phenotypes in women with climacteric syndrome in early postmenopause in order to optimize the algorithm for its early multidisciplinary diagnosis. Materials and methods. A cross-sectional study enrolled 133 women with CS in early postmenopause. The main group included 96 women with a waist circumference (WC) ≥80 cm; the comparison group comprised 37 women with a WC <80 cm. Assessment included medical history evaluation, the Greene Climacteric Scale, the Modified Menopausal Index (MMI), a visual analog scale (VAS) for hot flashes/hyperhidrosis, anthropometry and laboratory tests. Results. The prevalence of MS in women with climacteric syndrome and abdominal obesity was 62.5 %. The main phenotypes of metabolic syndrome were lipocentric, dyslipidemic, hypertensive, and renal. Patients in the main group exhibited a more severe course of climacteric syndrome versus the comparison group, according to the Greene scale (p < 0.001), the MMI (p < 0.001), and the hyperhidrosis VAS (p = 0.001). These data enabled the development of two models for optimizing diagnostic strategies. Conclusion. The high prevalence metabolic syndrome in women with abdominal obesity in early postmenopause highlights the comorbidity of climacteric and metabolic disorders. The developed models and algorithm optimize the early diagnosis of menopausal metabolic syndrome and ensure personalized multidisciplinary management of patients.